albuterol has been researched along with Muscle Spasm in 4 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antispasmogenic and spasmolytic effects of the calcium entry blocker verapamil were examined on histamine-induced guinea pig tracheal contraction in vitro in comparison with the beta 2-adrenergic agonist salbutamol." | 7.69 | Antispasmogenic and spasmolytic effects of verapamil and salbutamol, alone and in combination, on histamine-induced guinea pig tracheal contraction in vitro. ( Belcheva, A; Valcheva, S, 1994) |
| "The antispasmogenic and spasmolytic effects of the calcium entry blocker verapamil were examined on histamine-induced guinea pig tracheal contraction in vitro in comparison with the beta 2-adrenergic agonist salbutamol." | 3.69 | Antispasmogenic and spasmolytic effects of verapamil and salbutamol, alone and in combination, on histamine-induced guinea pig tracheal contraction in vitro. ( Belcheva, A; Valcheva, S, 1994) |
| " We summarized data relating to exacerbations and adverse events, particularly events related to COPD." | 2.49 | The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. ( Decramer, ML; Hanania, NA; Lötvall, JO; Yawn, BP, 2013) |
| "Levcromakalim was much less potent (427 fold) against the spasm evoked by KCl (80 mM) than against the spasm evoked by oxytocin (0." | 1.29 | Cellular localization of the inhibitory action of relaxin against uterine spasm. ( Hollingsworth, M; Hughes, SJ, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decramer, ML | 1 |
| Hanania, NA | 1 |
| Lötvall, JO | 1 |
| Yawn, BP | 1 |
| Valcheva, S | 1 |
| Belcheva, A | 1 |
| Hughes, SJ | 1 |
| Hollingsworth, M | 1 |
| Lisi, DM | 1 |
1 review available for albuterol and Muscle Spasm
| Article | Year |
|---|---|
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Blood Glucose; Cough; Ethanolamines; Formoterol Fuma | 2013 |
3 other studies available for albuterol and Muscle Spasm
| Article | Year |
|---|---|
Antispasmogenic and spasmolytic effects of verapamil and salbutamol, alone and in combination, on histamine-induced guinea pig tracheal contraction in vitro.
Topics: Albuterol; Animals; Guinea Pigs; Histamine; In Vitro Techniques; Male; Muscle, Smooth; Parasympathol | 1994 |
Cellular localization of the inhibitory action of relaxin against uterine spasm.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Benzopyrans; Calcium; Calcium Channel Agonists; Calciu | 1995 |
Muscle spasms and creatine phosphokinase elevation following salbutamol administration.
Topics: Adult; Albuterol; Creatine Kinase; Female; Humans; Muscular Diseases; Spasm; Thorax | 1989 |